FGFR3 Gene Alterations and Protein Expression in Paired TURBT and Radical Cystectomy Archival Specimens of Muscle-Invasive Bladder Cancer
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27198698 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Makito Miyake und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 3, Urinary Bladder Neoplasms, Cystectomy. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
This study investigated whether neoadjuvant chemotherapy (NAC) influences the detectability of fibroblast growth factor receptor 3 gene alterations (FGFR3alt) in muscle-invasive bladder cancer (MIBC). Among 173 patients who underwent radical cystectomy (RC), 70 had paired transurethral resection of bladder tumor (TURBT) and RC archival specimens available for FGFR3 RNA testing and immunohistochemical (IHC) analysis. FGFR3alt were detected in only six tumors (8.6%), and 13 RC specimens (19%) showed RNA test failure, predominantly in archival samples older than 10 years. The assay-success concordance of FGFR3 RNA test results between paired TURBT and RC specimens was high (73%), although one NAC-treated patient with FGFR3alt TURBT tissue converted to FGFR3-negative status in the RC specimen. IHC analysis demonstrated significantly higher FGFR3 protein expression in FGFR3alt tumors and a moderate correlation between paired TURBT and RC specimens, irrespective of NAC exposure. Because FGFR3 alterations were detected in only a small number of cases, the study was underpowered to evaluate whether NAC influences FGFR3alt detectability. These findings underscore the need for validation in larger, multi-institutional datasets and integrated molecular profiling to clarify the impact of chemotherapy on FGFR3-driven bladder cancer biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
- Department of Prostate Brachytherapy, https://ror.org/045ysha14Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.
ORCID-Profile: Makito Miyake, Yuki Oda, Yosuke Morizawa, Yasushi Nakai, Nobumichi Tanaka
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Miyake, M., Nishimura, N., Ohnishi, S., Oda, Y., Shimizu, T., Owari, T., Iida, K., Tachibana, A., Tomizawa, M., Ohnishi, K., Hori, S., Morizawa, Y., Gotoh, D., Nakai, Y., & Tanaka, N. (2026). FGFR3 Gene Alterations and Protein Expression in Paired TURBT and Radical Cystectomy Archival Specimens of Muscle-Invasive Bladder Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198698
Vancouver
Miyake M, Nishimura N, Ohnishi S, Oda Y, Shimizu T, Owari T, et al. FGFR3 Gene Alterations and Protein Expression in Paired TURBT and Radical Cystectomy Archival Specimens of Muscle-Invasive Bladder Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198698
BibTeX
@article{Miyake2026,
author = {Miyake, Makito and Nishimura, Nobutaka and Ohnishi, Sayuri and Oda, Yuki and Shimizu, Takuto and Owari, Takuya and Iida, Kota and Tachibana, Akira and Tomizawa, Mitsuru and Ohnishi, Kenta and Hori, Shunta and Morizawa, Yosuke and Gotoh, Daisuke and Nakai, Yasushi and Tanaka, Nobumichi},
title = {FGFR3 Gene Alterations and Protein Expression in Paired TURBT and Radical Cystectomy Archival Specimens of Muscle-Invasive Bladder Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27198698}
}
EUVIMED